Deep-vein thrombosis is an important complication of several inherited and
acquired disorders, but may also occur spontaneously, prevention of recurre
nt venous thrombosis and pulmonary embolism is the main reason for accurate
diagnosis and adequate treatment. This seminar discusses only symptomatic
deep-vein thrombosis. The diagnosis can be confirmed by objective tests in
only about 30% of patients with symptoms. Venous thromboembolic complicatio
ns happen in less than 1% of untreated patients in whom the presence of ven
ous thrombosis is rejected on the basis of serial ultrasonography or ultras
onography plus either D-dimer or clinical score. Initial anticoagulant trea
tment (intravenous or subcutaneous heparin) should continue until oral anti
coagulant treatment, started concurrently, increases the international norm
alised ratio above 2.0 for more than 24 h. The optimum duration of oral ant
icoagulant treatment is unresolved, but may be guided by the presence of te
mporary or persistent risk factors or presentation with recurrent venous th
romboembolism.